We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cipla Eyes Generic Challenge To Sanofi-Synthelabo's Plavix

Law360 (July 26, 2004, 12:00 AM EDT) -- Indian generic drug maker Cipla is planning to apply for approval to sell its version of Sanofi-Synthelabo's Plavix, the blood-thinning drug already at the center of Sanofi’s drawn-out patent litigation against...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.